Enanta Pharmaceuticals
ENTA
#8257
Rank
NZ$0.59 B
Marketcap
NZ$20.37
Share price
4.27%
Change (1 day)
-0.42%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2023 (TTM): NZ-$10.33

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$4.28. In 2022 the company made an earnings per share (EPS) of NZ-$10.33 a decrease over its 2021 EPS that were of NZ-$8.84.

EPS history for Enanta Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$10.33-0.02%
2022NZ-$10.3316.87%
2021NZ-$8.8472.92%
2020NZ-$5.11-267.44%
2019NZ$3.05-61.35%
2018NZ$7.90147.22%
2017NZ$3.20-460%
2016NZ-$0.89-114.88%
2015NZ$5.97-23.81%
2014NZ$7.83-244.12%
2013NZ-$5.43354.58%
2012NZ-$1.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.87-377.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.32-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$6.34-248.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$30.77-819.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.76-141.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.03-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA